# clm_EF7099311C58

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: research_and_development  
value: 1,416,476,000 United States dollar  
valid_from: 2018-12-31  
valid_to: 2019-12-31  
published: 2019-02-13  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_4875DCC74B8B  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals research and development: 1,416,476,000 United States dollar", as of 2018-12-31 (until 2019-12-31). Claim clm_EF7099311C58, https://asof.is/claim/clm_EF7099311C58, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532019000006/0000875320-19-000006-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-K FY2018, filed 2019-02-13  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532019000006/0000875320-19-000006-index.htm (primary, SEC EDGAR 10-K FY2018, published 2019-02-13)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | research_and_development | 1,324,625,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_EF7099311C58](/claim/clm_EF7099311C58.md) | [clm_C5B2018B6129](/claim/clm_C5B2018B6129.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.